Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Status Epilepticus

Treatments: Drug: Valproate

Study type: Observational

Funder types: Other

Identifiers

NCT01268904

0098-10-HYMC

Details and patient eligibility

About

To evaluate the safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures as part of seizure treatment protocol in pediatric ER

Enrollment: 50 estimated patients

Sex: All

Ages: 6 months to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Child with clinical presentation of status epilepticus

Exclusion criteria

• All others

Trial design

50 participants in 1 patient group

Pediatric status epilepticus

Treatment:

Drug: Valproate